Unclassified

Rates of Precipitated Withdrawal in a Trial of ED–Initiated Buprenorphine for Opioid Use Disorder | ClinicLens

To the Editor As addiction medicine physicians providing treatment for individuals using fentanyl, we appreciate the recent publication of a randomized clinical trial evaluating short-term treatment retention associated with a weekly extended-release buprenorphine injection initi

Medical Literature · Updated

← Back to articles
This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.